Regenerative Treatments for Hair Loss: PRP, Exosomes, and Emerging Therapies

Conclusions

• Regenerative approaches such as PRP and exosome-based therapies show promising potential for improving hair density, thickness, and overall scalp coverage in alopecia.
• Exosomes may promote hair regeneration by delivering bioactive cargo that activates dermal papilla cells and related growth pathways such as Wnt/β-catenin.
• Different exosome sources appear to vary in efficacy, with adipose-derived mesenchymal stem cell exosomes sometimes performing better than PRP-derived exosomes in experimental models.
• Early human and animal studies suggest benefit, but the current evidence base remains limited, heterogeneous, and not yet definitive.
• There are currently no FDA-approved exosome therapies for hair restoration, and ongoing trials have not yet established approved treatments for alopecia.
• A major barrier to progress is the lack of standardized methods to define, isolate, characterize, and compare extracellular vesicle subtypes.
• Many published studies have weak EV characterization and uncertain functional attribution, making it unclear whether observed effects are truly due to exosomes or to other sample components.
• Future progress in regenerative hair therapy will require stronger standardization, better manufacturing and storage controls, and improved safety data before broad clinical adoption.